Restart Life Sciences Corp.
HEAL
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -219.57% | -116.08% | -700.86% | -9,169.79% | 18.06% |
| Total Depreciation and Amortization | 614.29% | 153.33% | -25.00% | -23.53% | -22.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2,382.70% | 10,761.29% | 256.53% | 215.26% | -- |
| Change in Net Operating Assets | -342.36% | -173.15% | -192.94% | -72.16% | -72.03% |
| Cash from Operations | -201.56% | -119.41% | -867.42% | -403.35% | -380.08% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1,566.67% | 1,566.67% | 233.33% | -75.00% | -75.00% |
| Total Debt Repaid | 83.25% | 93.98% | -- | -- | -- |
| Issuance of Common Stock | 295.04% | 275.04% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 411.25% | 391.07% | 2,877.90% | 655.28% | 655.28% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 228.01% | 318.62% | 47,104.17% | 514.75% | 2,927.03% |